Market Intelligence chevron_right Medical Care chevron_right Nasopharyngeal Cancer
Global Report 2022

Global and United States Nasopharyngeal Cancer Market Report & Forecast 2024-2031

calendar_todayPublished: Jun 2022 descriptionPages: 91 categoryCategory: Medical Care
cloud_downloadRequest Sample Report
mailPre-Order Enquiry
local_offerGet Discount 
1 Study Coverage
    1.1 Nasopharyngeal Cancer Revenue in Nasopharyngeal Cancer Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Nasopharyngeal Cancer Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Nasopharyngeal Cancer Market Size for the Year 2017-2028
        1.2.2 Global Nasopharyngeal Cancer Market Size for the Year 2017-2028
    1.3 Nasopharyngeal Cancer Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Nasopharyngeal Cancer in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Nasopharyngeal Cancer Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Nasopharyngeal Cancer Market Dynamics
        1.4.1 Nasopharyngeal Cancer Industry Trends
        1.4.2 Nasopharyngeal Cancer Market Drivers
        1.4.3 Nasopharyngeal Cancer Market Challenges
        1.4.4 Nasopharyngeal Cancer Market Restraints
    1.5 Study Objectives
    1.6 Years Considered
2 Nasopharyngeal Cancer by Type
    2.1 Nasopharyngeal Cancer Market Segment by Type
        2.1.1 Surgery
        2.1.2 Radiation
        2.1.3 Chemotherapy
    2.2 Global Nasopharyngeal Cancer Market Size by Type (2017, 2022 & 2028)
    2.3 Global Nasopharyngeal Cancer Market Size by Type (2017-2028)
    2.4 United States Nasopharyngeal Cancer Market Size by Type (2017, 2022 & 2028)
    2.5 United States Nasopharyngeal Cancer Market Size by Type (2017-2028)
3 Nasopharyngeal Cancer by Application
    3.1 Nasopharyngeal Cancer Market Segment by Application
        3.1.1 Hospitals
        3.1.2 Clinics
        3.1.3 Cancer Treatment and Rehabilitation Centers
    3.2 Global Nasopharyngeal Cancer Market Size by Application (2017, 2022 & 2028)
    3.3 Global Nasopharyngeal Cancer Market Size by Application (2017-2028)
    3.4 United States Nasopharyngeal Cancer Market Size by Application (2017, 2022 & 2028)
    3.5 United States Nasopharyngeal Cancer Market Size by Application (2017-2028)
4 Global Nasopharyngeal Cancer Competitor Landscape by Company
    4.1 Global Nasopharyngeal Cancer Market Size by Company
        4.1.1 Top Global Nasopharyngeal Cancer Companies Ranked by Revenue (2021)
        4.1.2 Global Nasopharyngeal Cancer Revenue by Player (2017-2022)
    4.2 Global Nasopharyngeal Cancer Concentration Ratio (CR)
        4.2.1 Nasopharyngeal Cancer Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Nasopharyngeal Cancer in 2021
        4.2.3 Global Nasopharyngeal Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Nasopharyngeal Cancer Headquarters, Revenue in Nasopharyngeal Cancer Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Nasopharyngeal Cancer Headquarters and Area Served
        4.3.2 Global Nasopharyngeal Cancer Companies Revenue in Nasopharyngeal Cancer Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Nasopharyngeal Cancer Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Nasopharyngeal Cancer Market Size by Company
        4.5.1 Top Nasopharyngeal Cancer Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Nasopharyngeal Cancer Revenue by Players (2020, 2021 & 2022)
5 Global Nasopharyngeal Cancer Market Size by Region
    5.1 Global Nasopharyngeal Cancer Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Nasopharyngeal Cancer Market Size by Region (2017-2028)
        5.2.1 Global Nasopharyngeal Cancer Market Size by Region: 2017-2022
        5.2.2 Global Nasopharyngeal Cancer Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Nasopharyngeal Cancer Market Size YoY Growth 2017-2028
        6.1.2 North America Nasopharyngeal Cancer Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Nasopharyngeal Cancer Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Nasopharyngeal Cancer Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Nasopharyngeal Cancer Market Size YoY Growth 2017-2028
        6.3.2 Europe Nasopharyngeal Cancer Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Nasopharyngeal Cancer Market Size YoY Growth 2017-2028
        6.4.2 Latin America Nasopharyngeal Cancer Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Nasopharyngeal Cancer Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Nasopharyngeal Cancer Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 UAE
7 Company Profiles
    7.1 Roche
        7.1.1 Roche Company Details
        7.1.2 Roche Business Overview
        7.1.3 Roche Nasopharyngeal Cancer Introduction
        7.1.4 Roche Revenue in Nasopharyngeal Cancer Business (2017-2022)
        7.1.5 Roche Recent Development
    7.2 Sanofi
        7.2.1 Sanofi Company Details
        7.2.2 Sanofi Business Overview
        7.2.3 Sanofi Nasopharyngeal Cancer Introduction
        7.2.4 Sanofi Revenue in Nasopharyngeal Cancer Business (2017-2022)
        7.2.5 Sanofi Recent Development
    7.3 Merck
        7.3.1 Merck Company Details
        7.3.2 Merck Business Overview
        7.3.3 Merck Nasopharyngeal Cancer Introduction
        7.3.4 Merck Revenue in Nasopharyngeal Cancer Business (2017-2022)
        7.3.5 Merck Recent Development
    7.4 Cyclacel Pharmaceuticals
        7.4.1 Cyclacel Pharmaceuticals Company Details
        7.4.2 Cyclacel Pharmaceuticals Business Overview
        7.4.3 Cyclacel Pharmaceuticals Nasopharyngeal Cancer Introduction
        7.4.4 Cyclacel Pharmaceuticals Revenue in Nasopharyngeal Cancer Business (2017-2022)
        7.4.5 Cyclacel Pharmaceuticals Recent Development
    7.5 Celgene
        7.5.1 Celgene Company Details
        7.5.2 Celgene Business Overview
        7.5.3 Celgene Nasopharyngeal Cancer Introduction
        7.5.4 Celgene Revenue in Nasopharyngeal Cancer Business (2017-2022)
        7.5.5 Celgene Recent Development
    7.6 BioDiem
        7.6.1 BioDiem Company Details
        7.6.2 BioDiem Business Overview
        7.6.3 BioDiem Nasopharyngeal Cancer Introduction
        7.6.4 BioDiem Revenue in Nasopharyngeal Cancer Business (2017-2022)
        7.6.5 BioDiem Recent Development
8 Research Findings and Conclusion
9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer

List of Tables
    Table 1. Nasopharyngeal Cancer Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Nasopharyngeal Cancer Market Trends
    Table 3. Nasopharyngeal Cancer Market Drivers
    Table 4. Nasopharyngeal Cancer Market Challenges
    Table 5. Nasopharyngeal Cancer Market Restraints
    Table 6. Global Nasopharyngeal Cancer Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Nasopharyngeal Cancer Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Nasopharyngeal Cancer Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Nasopharyngeal Cancer Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Nasopharyngeal Cancer Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Nasopharyngeal Cancer Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Nasopharyngeal Cancer Revenue Share by Player, 2017-2022
    Table 13. Global Nasopharyngeal Cancer Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Nasopharyngeal Cancer by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nasopharyngeal Cancer as of 2021)
    Table 15. Top Players of Nasopharyngeal Cancer in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Nasopharyngeal Cancer Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Nasopharyngeal Cancer Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Nasopharyngeal Cancer Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Nasopharyngeal Cancer Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Nasopharyngeal Cancer Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Nasopharyngeal Cancer Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Nasopharyngeal Cancer Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Nasopharyngeal Cancer Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Nasopharyngeal Cancer Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Nasopharyngeal Cancer Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Nasopharyngeal Cancer Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Nasopharyngeal Cancer Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Nasopharyngeal Cancer Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Roche Company Details
    Table 31. Roche Business Overview
    Table 32. Roche Nasopharyngeal Cancer Product
    Table 33. Roche Revenue in Nasopharyngeal Cancer Business (2017-2022) & (US$ Million)
    Table 34. Roche Recent Development
    Table 35. Sanofi Company Details
    Table 36. Sanofi Business Overview
    Table 37. Sanofi Nasopharyngeal Cancer Product
    Table 38. Sanofi Revenue in Nasopharyngeal Cancer Business (2017-2022) & (US$ Million)
    Table 39. Sanofi Recent Development
    Table 40. Merck Company Details
    Table 41. Merck Business Overview
    Table 42. Merck Nasopharyngeal Cancer Product
    Table 43. Merck Revenue in Nasopharyngeal Cancer Business (2017-2022) & (US$ Million)
    Table 44. Merck Recent Development
    Table 45. Cyclacel Pharmaceuticals Company Details
    Table 46. Cyclacel Pharmaceuticals Business Overview
    Table 47. Cyclacel Pharmaceuticals Nasopharyngeal Cancer Product
    Table 48. Cyclacel Pharmaceuticals Revenue in Nasopharyngeal Cancer Business (2017-2022) & (US$ Million)
    Table 49. Cyclacel Pharmaceuticals Recent Development
    Table 50. Celgene Company Details
    Table 51. Celgene Business Overview
    Table 52. Celgene Nasopharyngeal Cancer Product
    Table 53. Celgene Revenue in Nasopharyngeal Cancer Business (2017-2022) & (US$ Million)
    Table 54. Celgene Recent Development
    Table 55. BioDiem Company Details
    Table 56. BioDiem Business Overview
    Table 57. BioDiem Nasopharyngeal Cancer Product
    Table 58. BioDiem Revenue in Nasopharyngeal Cancer Business (2017-2022) & (US$ Million)
    Table 59. BioDiem Recent Development
    Table 60. Research Programs/Design for This Report
    Table 61. Key Data Information from Secondary Sources
    Table 62. Key Data Information from Primary Sources
List of Figures
    Figure 1. Nasopharyngeal Cancer Product Picture
    Figure 2. Global Nasopharyngeal Cancer Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Nasopharyngeal Cancer Market Size 2017-2028 (US$ Million)
    Figure 4. United States Nasopharyngeal Cancer Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Nasopharyngeal Cancer Market Size 2017-2028 (US$ Million)
    Figure 6. United States Nasopharyngeal Cancer Market Share in Global 2017-2028
    Figure 7. Nasopharyngeal Cancer Report Years Considered
    Figure 8. Product Picture of Surgery
    Figure 9. Product Picture of Radiation
    Figure 10. Product Picture of Chemotherapy
    Figure 11. Global Nasopharyngeal Cancer Market Share by Type in 2022 & 2028
    Figure 12. Global Nasopharyngeal Cancer Market Size by Type (2017-2028) & (US$ Million)
    Figure 13. Global Nasopharyngeal Cancer Market Share by Type (2017-2028)
    Figure 14. United States Nasopharyngeal Cancer Market Share by Type in 2022 & 2028
    Figure 15. United States Nasopharyngeal Cancer Market Size by Type (2017-2028) & (US$ Million)
    Figure 16. United States Nasopharyngeal Cancer Market Share by Type (2017-2028)
    Figure 17. Product Picture of Hospitals
    Figure 18. Product Picture of Clinics
    Figure 19. Product Picture of Cancer Treatment and Rehabilitation Centers
    Figure 20. Global Nasopharyngeal Cancer Market Share by Application in 2022 & 2028
    Figure 21. Global Nasopharyngeal Cancer Market Size by Application (2017-2028) & (US$ Million)
    Figure 22. Global Nasopharyngeal Cancer Market Share by Application (2017-2028)
    Figure 23. United States Nasopharyngeal Cancer Market Share by Application in 2022 & 2028
    Figure 24. United States Nasopharyngeal Cancer Market Size by Application (2017-2028) & (US$ Million)
    Figure 25. United States Nasopharyngeal Cancer Market Share by Application (2017-2028)
    Figure 26. North America Nasopharyngeal Cancer Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 27. U.S. Nasopharyngeal Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 28. Canada Nasopharyngeal Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 29. Europe Nasopharyngeal Cancer Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 30. Germany Nasopharyngeal Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. France Nasopharyngeal Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. U.K. Nasopharyngeal Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. Italy Nasopharyngeal Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. Russia Nasopharyngeal Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. Asia-Pacific Nasopharyngeal Cancer Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 36. China Nasopharyngeal Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. Japan Nasopharyngeal Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. South Korea Nasopharyngeal Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. India Nasopharyngeal Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. Australia Nasopharyngeal Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Taiwan Nasopharyngeal Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Indonesia Nasopharyngeal Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Thailand Nasopharyngeal Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Malaysia Nasopharyngeal Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Philippines Nasopharyngeal Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Latin America Nasopharyngeal Cancer Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 47. Mexico Nasopharyngeal Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Brazil Nasopharyngeal Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Argentina Nasopharyngeal Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Middle East & Africa Nasopharyngeal Cancer Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 51. Turkey Nasopharyngeal Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Saudi Arabia Nasopharyngeal Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. UAE Nasopharyngeal Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Roche Revenue Growth Rate in Nasopharyngeal Cancer Business (2017-2022)
    Figure 55. Sanofi Revenue Growth Rate in Nasopharyngeal Cancer Business (2017-2022)
    Figure 56. Merck Revenue Growth Rate in Nasopharyngeal Cancer Business (2017-2022)
    Figure 57. Cyclacel Pharmaceuticals Revenue Growth Rate in Nasopharyngeal Cancer Business (2017-2022)
    Figure 58. Celgene Revenue Growth Rate in Nasopharyngeal Cancer Business (2017-2022)
    Figure 59. BioDiem Revenue Growth Rate in Nasopharyngeal Cancer Business (2017-2022)
    Figure 60. Bottom-up and Top-down Approaches for This Report
    Figure 61. Data Triangulation
    Figure 62. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Roche
Sanofi
Merck
Cyclacel Pharmaceuticals
Celgene
BioDiem

Frequently Asked Questions

What is the USP of the report? expand_more
Nasopharyngeal Cancer report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
What are the key content of the report? expand_more
Nasopharyngeal Cancer report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
What are the value propositions and opportunities offered in this market research report? expand_more
Nasopharyngeal Cancer report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.